Authors: PREISACK MB BAILDON R ESCHENFELDER V FOLEY D GARCIA E KALTENBACH R MEISNER C SELBMANN HK SERRUYS PW SHIU MF SUJATTA M BONAN R KARSCH KR

Citation: Mb. Preisack et al., LOW-MOLECULAR-WEIGHT HEPARIN, REVIPARIN AFTER PTCA - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, STANDARD HEPARIN AND PLACEBO-CONTROLLED MULTICENTRICAL STUDY (REDUCE TRIAL), Zeitschrift fur Kardiologie, 86(8), 1997, pp. 581-591

Authors: KARSCH KR PREISACK MB BAILDON R ESCHENFELDER V FOLEY D GARCIA EJ KALTENBACH M MEISNER C SELBMANN HK SERRUYS PW SHIU MF SUJATTA M BONAN R

Citation: Kr. Karsch et al., LOW-MOLECULAR-WEIGHT HEPARIN (REVIPARIN) IN PERCUTANEOUS TRANSLUMINALCORONARY ANGIOPLASTY - RESULTS OF A RANDOMIZED, DOUBLE-BLIND, UNFRACTIONATED HEPARIN AND PLACEBO-CONTROLLED, MULTICENTER TRIAL (REDUCE TRIAL), Journal of the American College of Cardiology, 28(6), 1996, pp. 1437-1443

Authors: SCHMID KM PREISACK M VOELKER W SUJATTA M KARSCH KR

Citation: Km. Schmid et al., 1ST CLINICAL-EXPERIENCE WITH LOW-MOLECULAR-WEIGHT HEPARIN LU-47311 (REVIPARIN) FOR PREVENTION OF RESTENOSIS AFTER PERCUTANEOUS TRANSLUMINALCORONARY ANGIOPLASTY, Seminars in thrombosis and hemostasis, 19, 1993, pp. 155-159

Authors: HAAS P BREDDIN HK KAKKAR VV VERMYLEN J TENCATE JW BARROWCLIFFE TW HEUCK C HARENBERG J BASICMICIC M BACHER P YIN ET ABILDGARD U SAMAMA M PLANES A ERIKSSON B LEYVRAZ PF BACHER P BERGQVIST D FOBBE F BORRIS L NICOLAIDES A BREYER HG VANDENBROEK MD BERGQVIST D TOULEMONDE F KAKKAR VV WEBER E HARENBERG J HULL RC KIRCHMAIER CM BREDDIN HK VETTERMANN J WENZEL E HAAS S SASAHARA A AMANN FW SUJATTA M CAPRINI JA THOMAS D FAREED J

Citation: P. Haas et al., REPORT ON THE INTERNATIONAL-SYMPOSIUM ON LOW-MOLECULAR-WEIGHT HEPARINS AND RELATED POLYSACCHARIDES MUNICH, GERMANY, JUNE 27 AND 28, 1991, Seminars in thrombosis and hemostasis, 19, 1993, pp. 217-226